NCT07463677 2026-03-11
Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
Clinical Trials
1 trialsPhase 2 × Carcinoma, Non-Small-Cell Lung × 26S proteasome non-ATPase regulatory subunit 13 × Clear all